Hospitalisation

DefinitionNLM MeSH D006760

The confinement of a patient in a hospital.

Source: U.S. National Library of Medicine — MeSH (Hospitalization)

Drugs reporting Hospitalisation (127)

Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.

1. 1Alvimopan1944%
2. 2Toripalimab220%
3. 3Glucosamine217%
4. 4Dichromate Ion117%
5. 5Daprodustat25815%
6. 6Cinacalcet6,95414%
7. 7Avacopan76613%
8. 8Olutasidenib3413%
9. 9Givosiran15912%
10. 10Darbepoetin Alfa6,11712%
11. 11Vutrisiran23811%
12. 12Adagrasib10911%
13. 13Lumacaftor88710%
14. 14Mecamylamine110%
15. 15Clozapine12,26210.0%
16. 16Cannabidiol2,2479.9%
17. 17Maribavir2239.6%
18. 18Ivacaftor3,0899.2%
19. 19Rifaximin1,7638.7%
20. 20Amikacin1,3817.6%
21. 21Zilucoplan497.2%
22. 22Riociguat2,2977.2%
23. 23Patiromer9707.1%
24. 24Carglumic Acid506.8%
25. 25Fostamatinib4406.8%
26. 26Dornase Alfa1,3016.7%
27. 27Setmelanotide176.5%
28. 28Brensocatib516.4%
29. 29Deutivacaftor316.3%
30. 30Vanzacaftor316.3%
31. 31Ripretinib3136.3%
32. 32Ibalizumab336.2%
33. 33Macitentan4,0796.0%
34. 34Lumasiran205.8%
35. 35Tenapanor705.7%
36. 36Selexipag1,4255.6%
37. 37Ciltacabtagene Autoleucel2835.6%
38. 38Palmitate1,7775.6%
39. 39Aztreonam3855.4%
40. 40Metyrosine45.3%
41. 41Enasidenib1685.2%
42. 42Lusutrombopag25.1%
43. 43Amylase3275.1%
44. 44Protease3275.1%
45. 45Tezacaftor9065.1%
46. 46Epoprostenol6555.1%
47. 47Lipase3314.8%
48. 48Patisiran1324.7%
49. 49Pemigatinib374.7%
50. 50Dordaviprone24.7%
51. 51Fenfluramine2004.6%
52. 52Duvelisib354.6%
53. 53Triheptanoin244.6%
54. 54Rozanolixizumab414.6%
55. 55Evinacumab104.5%
56. 56Teduglutide5914.5%
57. 57Belumosudil1324.4%
58. 58Esketamine7474.4%
59. 59Efgartigimod Alfa1754.3%
60. 60Mepolizumab2,0614.3%
61. 61Telotristat2394.2%
62. 62Telotristat Ethyl2394.2%
63. 63Protriptyline44.2%
64. 64Paliperidone2,1574.1%
65. 65Tetrabenazine2974.1%
66. 66Neratinib914.0%
67. 67Stiripentol814.0%
68. 68Tobramycin1,0523.8%
69. 69Omadacycline593.8%
70. 70Glutamine1933.7%
71. 71Garadacimab113.5%
72. 72Repotrectinib83.5%
73. 73Romosozumab4373.5%
74. 74Elexacaftor4193.5%
75. 75Momelotinib393.3%
76. 76Sotatercept1293.3%
77. 77Dasatinib1,2043.3%
78. 78Aripiprazole Lauroxil1433.2%
79. 79Somapacitan43.1%
80. 80Hemin163.0%
81. 81Metreleptin373.0%
82. 82Caplacizumab482.9%
83. 83Letermovir872.9%
84. 84Chlorothiazide372.9%
85. 85Sucroferric Oxyhydroxide862.9%
86. 86Trientine132.8%
87. 87Belatacept1252.7%
88. 88Rufinamide682.7%
89. 89Ponatinib1372.7%
90. 90Abiraterone1,0812.7%
91. 91Valbenazine6572.7%
92. 92Interferon Gamma-1b372.7%
93. 93Romiplostim3812.6%
94. 94Eculizumab1,3612.6%
95. 95Polystyrene Sulfonate402.5%
96. 96Sodium Polystyrene Sulfonate402.5%
97. 97Sotagliflozin132.5%
98. 98Tucatinib1672.5%
99. 99Pirtobrutinib172.4%
100. 100Methylnaltrexone352.4%
101. 101Calcifediol532.3%
102. 102Alglucosidase Alfa542.3%
103. 103Vigabatrin3272.3%
104. 104Glycerol Phenylbutyrate302.3%
105. 105Cenobamate1812.2%
106. 106Rolapitant122.2%
107. 107Levocarnitine772.2%
108. 108Venetoclax1,3052.2%
109. 109Crofelemer52.2%
110. 110Ferric Citrate472.2%
111. 111Istradefylline1262.2%
112. 112Umeclidinium1,3342.1%
113. 113Apalutamide2332.1%
114. 114Sevelamer2432.0%
115. 115Vericiguat192.0%
116. 116Belzutifan272.0%
117. 117Ibrutinib1,6012.0%
118. 118Nipocalimab31.9%
119. 119Deutetrabenazine1251.8%
120. 120Epcoritamab211.8%
121. 121Ferric Maltol181.8%
122. 122Maltol181.8%
123. 123Mavacamten731.7%
124. 124Luspatercept381.7%
125. 125Lurbinectedin171.6%
126. 126Voxelotor3071.4%
127. 127Ganaxolone81.3%

Related reactions

Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.

• Therapy Interrupted19 shared · 0.12
• Product Dose Omission Issue57 shared · 0.11
• Death97 shared · 0.10
• Cystic Fibrosis12 shared · 0.09
• Infective Pulmonary Exacerbation Of Cystic Fibrosis12 shared · 0.09
• Adverse Event12 shared · 0.08
• Pneumonia67 shared · 0.08
• Infection18 shared · 0.08
• Abdominal Pain Upper31 shared · 0.08
• Treatment Noncompliance11 shared · 0.07

Literature

Recent PubMed references pinned to Hospitalization as a MeSH major topic. About the reaction term itself — not about any specific drug.

• Reduction in same-day readmission rate for orthognathic surgery with a new enhanced recovery after surgery protocol.
  Clinical oral investigations · 2026 · Bencherqui S, Lauwers F, Mure M, et al.
  PMID 42207307DOI 10.1007/s00784-026-06841-8
• Hyperkalemia in Heart Failure Hospitalizations: An Underreported Contributor to Poor Outcomes and Higher Costs in Brazil.
  Arquivos brasileiros de cardiologia · 2026 · Pecoits-Filho R, Rocha PT, Costa MCD, et al.
  PMID 42207122DOI 10.36660/abc.20250394
• Outcomes and other characteristics of the nutritional screening and assessment tools validation processes in hospitalized adults: a systematic review.
  Einstein (Sao Paulo, Brazil) · 2026 · Bergamasco GGL, Lima BR, Araújo KA, et al.
  PMID 42207116DOI 10.31744/einstein_journal/2026RW1855
• GENERATIVE AI TOWARDS A COMPARATIVE ANALYSIS OF HOSPITALIZATION RATES AMONG PATIENTS WITH ULCERATIVE COLITIS TREATED WITH INFLIXIMAB, VEDOLIZUMAB, AND TOFACITINIB IN THE PUBLIC HEALTHCARE SYSTEM IN BRAZIL: A NATIONWIDE STUDY.
  Arquivos de gastroenterologia · 2026 · Valverde DA, Quaresma AB, Villamil MPG, et al.
  PMID 42207071DOI 10.1590/S0004-2803.24612025-066
• Unveiling the burden of long covid in hospital and community settings: findings from the Post-Acute Sequelae of SARS-CoV-2 Network (PASCNET) cohort study in Italy's pandemic epicentre.
  BMJ open · 2026 · Antolini L, Valsecchi MG, Bussi A, et al.
  PMID 42203277DOI 10.1136/bmjopen-2025-114399
• Nurses' Perceived Barriers to the Implementation and Sustainability of Best Patient Safety in Handover in the Clinical Setting: Cross-Sectional Survey Study.
  Critical care nursing quarterly · 2026 · Shalaby Khalaf Mahran G, Fadl Abd Elkhalik E, Adel Mohamed B, et al.
  PMID 42202157DOI 10.1097/CNQ.0000000000000613